We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sorafenib for Residue Disease After Resection With Curative Intent (SECURE)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01751763
First Posted: December 18, 2012
Last Update Posted: September 25, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Bayer
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 8, 2017
  Primary Completion Date: December 31, 2016 (Final data collection date for primary outcome measure)